HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ajay J Kirtane Selected Research

N(2)-(3-trifluoromethylphenyl)guanine

2/2009Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction.
11/2007Temporal changes in TIMI myocardial perfusion grade in relation to epicardial flow, ST-resolution and left ventricular function after primary percutaneous coronary intervention.
10/2006Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
9/2006Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy.
2/2005Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.
11/2004Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
9/2004Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.
6/2004Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ajay J Kirtane Research Topics

Disease

108Myocardial Infarction
11/2022 - 07/2004
92Thrombosis (Thrombus)
11/2022 - 04/2004
69Hemorrhage
11/2022 - 06/2006
48ST Elevation Myocardial Infarction
01/2021 - 06/2004
41Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2008
34Acute Coronary Syndrome
11/2021 - 06/2005
30Death (Near-Death Experience)
01/2022 - 10/2007
28Coronary Artery Disease (Coronary Atherosclerosis)
12/2022 - 02/2005
19Hypertension (High Blood Pressure)
11/2022 - 02/2005
18Ischemia
01/2020 - 05/2006
17Heart Failure
11/2022 - 02/2005
17Diabetes Mellitus
01/2020 - 05/2006
16COVID-19
01/2022 - 01/2020
16Stroke (Strokes)
01/2022 - 11/2011
12Aortic Valve Stenosis (Aortic Stenosis)
01/2021 - 04/2011
10Chronic Renal Insufficiency
10/2020 - 03/2008
10Infarction (Infarctions)
10/2016 - 03/2004
9Cardiogenic Shock
01/2022 - 05/2015
8Anemia
01/2020 - 09/2009
7Pathologic Constriction (Stenosis)
01/2021 - 02/2005
6Peripheral Arterial Disease
01/2022 - 10/2015
5Rupture
08/2017 - 06/2003
4Ischemic Stroke
01/2022 - 11/2013
4Coronary Thrombosis
10/2020 - 05/2016
4Frailty
01/2020 - 09/2012
4Hyperplasia
01/2019 - 01/2007
4Left Ventricular Dysfunction
12/2018 - 01/2013
4Atherosclerotic Plaque (Atheroma)
12/2017 - 01/2016
3AIDS-Related Complex (ARC)
01/2022 - 04/2014
3Atrial Fibrillation
01/2022 - 01/2014
3Critical Illness (Critically Ill)
10/2021 - 12/2020
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 05/2015
3Unstable Angina
01/2021 - 08/2006
3Thrombocytopenia (Thrombopenia)
11/2018 - 04/2014
3Renal Insufficiency (Renal Failure)
11/2018 - 04/2014
3Pulmonary Edema
05/2017 - 04/2007
3Coronary Disease (Coronary Heart Disease)
02/2017 - 07/2013
3Inflammation (Inflammations)
04/2007 - 09/2005
2Thromboembolism
01/2021 - 12/2020
2Virus Diseases (Viral Diseases)
01/2021 - 08/2020
2Pulmonary Embolism
11/2020 - 09/2017
2Chest Pain (Chest Pains)
10/2020 - 01/2017
2Hemolysis
01/2020 - 01/2019
2Necrosis
01/2020 - 05/2006

Drug/Important Bio-Agent (IBA)

28omega-Chloroacetophenone (Mace)IBA
01/2022 - 03/2008
17Clopidogrel (Plavix)FDA Link
01/2022 - 05/2006
15bivalirudin (Angiomax)FDA Link
01/2020 - 05/2006
14MetalsIBA
01/2020 - 04/2004
13Heparin (Liquaemin)FDA LinkGeneric
01/2020 - 06/2006
122'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022 - 08/2014
11Glycoproteins (Glycoprotein)IBA
02/2015 - 07/2004
10salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2018
9Eptifibatide (Integrilin)FDA Link
01/2014 - 07/2004
8zotarolimusIBA
01/2022 - 10/2009
8CalciumIBA
01/2022 - 02/2005
8Pharmaceutical PreparationsIBA
11/2021 - 06/2003
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 10/2005
8CreatinineIBA
01/2021 - 06/2005
8N(2)-(3-trifluoromethylphenyl)guanineIBA
02/2009 - 06/2004
7Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 01/2008
7Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 01/2018
7PolymersIBA
01/2022 - 04/2012
7EverolimusFDA Link
01/2021 - 04/2012
7Sirolimus (Rapamycin)FDA Link
04/2014 - 04/2004
7Paclitaxel (Taxol)FDA LinkGeneric
12/2013 - 03/2007
6AnticoagulantsIBA
01/2022 - 12/2011
6Biomarkers (Surrogate Marker)IBA
01/2020 - 05/2006
6Hemoglobins (Hemoglobin)IBA
10/2018 - 07/2012
4Enoxaparin (Lovenox)FDA LinkGeneric
01/2021 - 02/2005
4TroponinIBA
10/2020 - 05/2006
4Insulin (Novolin)FDA Link
03/2017 - 10/2007
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 04/2007
3Abciximab (ReoPro)FDA Link
10/2016 - 11/2007
3Phenobarbital (Luminal)FDA Link
01/2016 - 02/2005
3S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA
02/2009 - 03/2004
3AntithrombinsIBA
05/2008 - 02/2005
3C-Reactive ProteinIBA
05/2006 - 09/2005
2Biological ProductsIBA
12/2022 - 01/2019
2Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2021 - 10/2006
2AlbuminsIBA
01/2020 - 07/2015
22- amino- 3- cyano- 6- ethyl- 5- (4- pyridyl)pyridineIBA
01/2020 - 01/2020

Therapy/Procedure

111Stents
11/2022 - 04/2004
92Percutaneous Coronary Intervention
01/2022 - 07/2004
65Therapeutics
01/2022 - 02/2005
45Drug-Eluting Stents
01/2022 - 06/2003
24Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 04/2007
22Transcatheter Aortic Valve Replacement
01/2022 - 04/2011
14Thrombolytic Therapy
01/2021 - 06/2004
12Denervation
01/2022 - 05/2015
8Extracorporeal Membrane Oxygenation
01/2022 - 05/2015
8Catheters
01/2021 - 09/2012
7Heart-Assist Devices
01/2022 - 01/2015
6Length of Stay
01/2018 - 09/2012
5Critical Care (Surgical Intensive Care)
01/2022 - 05/2012
5Patient Readmission
01/2022 - 11/2015
4Thrombectomy
10/2020 - 01/2014
2Sympathectomy (Sympathectomies)
10/2020 - 01/2019
2Endovascular Procedures
07/2020 - 01/2018
2Cannula
01/2020 - 05/2015
2Heart Transplantation (Grafting, Heart)
12/2018 - 06/2012